FDA Inspection
Fresenius Kabi iPSUM SrlFresenius Kabi iPSUM Srl – FDA Inspection, Dec 15, 2009
Record Details
This FDA Inspection record concerns Fresenius Kabi iPSUM Srl, with an inspection on December 15, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Fresenius Kabi iPSUM Srl
- Inspection Date
- December 15, 2009
- Product Type
- Drugs
View Company Profile
ID · 4df20019-fbd9-47f5-be29-6dca36ffe9a8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 638402
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fresenius Kabi iPSUM Srl
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 21, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi iPSUM Srl
- FDA Inspection 1277643 - 2022-01-21
- FDA Inspection 1123992 - 2019-12-06
- FDA Inspection 1078083 - 2017-12-15
- FDA Inspection 993733 - 2016-11-17
- FDA Inspection 854585 - 2013-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.